BRYNJELSEN SEAN (President & CEO) sold 9.4% of their position (100K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $6.09M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/20/2026ACC: 0001437749-26-028651
DirectorOfficer· President & CEO
Since Nov 2018
-100K
Net shares
Net seller
$6.09M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
100K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−8.98K
Price / share
$62.65
Trade value
$562.47K
% of position
0.8%
8/19/2026
1.06M→1.05M
Common Stock
Direct
Shares
−47.31K
Price / share
$60.17
Trade value
$2.85M
% of position
4.5%
8/20/2026
1.05M→1M
Common Stock
Direct
Shares
−36.37K
Price / share
$61.11
Trade value
$2.22M
% of position
3.6%
8/20/2026
1M→968.54K
Common Stock
Direct
Shares
−7.34K
Price / share
$62.12
Trade value
$456.09K
% of position
0.8%
8/20/2026
968.54K→961.19K
Total
Net shares
−100K
Net value
-$6.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2026 | S · Sale | −8.98K | $62.65 | $562.47K | 0.8% | 1.06M | 1.05M |
| Common Stock Direct | 8/20/2026 | S · Sale | −47.31K | $60.17 | $2.85M | 4.5% | 1.05M | 1M |
| Common Stock Direct | 8/20/2026 | S · Sale | −36.37K | $61.11 | $2.22M | 3.6% | 1M | 968.54K |
| Common Stock Direct | 8/20/2026 | S · Sale | −7.34K | $62.12 | $456.09K | 0.8% | 968.54K | 961.19K |
| Total | −100K | -$6.09M | ||||||
Derivative Transactions0
No derivative transactions reported